Condensed Balance Sheets (unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 19,504	$ 10,775
Short-term Investments	43,543	56,814
Prepaid expenses and other current assets	2,545	2,249
Total current assets	65,592	69,838
Right-of-use assets	589	736
Property and equipment	7	9
Other long-term assets	35	33
Total assets	66,223	70,616
Current liabilities:
Accounts payable	1,939	1,310
Accrued research and development expenses	3,790	4,168
Accrued compensation and related expenses	1,238	2,438
Accrued other expenses	559	490
Right-of-use liabilities, current portion	375	358
Total current liabilities	7,901	8,764
Right-of-use liabilities, net of current portion	214	382
Commitments and contingencies (see Note 9)
Stockholders' equity:
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	2	1
Additional paid-in-capital	170,993	148,303
Accumulated other comprehensive loss	(290)	(692)
Accumulated deficit	(112,597)	(86,142)
Total stockholders' equity	58,108	61,470
Total liabilities and stockholders' equity	66,223	70,616
Non-Voting Common Stock [Member]
Stockholders' equity:
Common Stock, Value, Issued	$ 0	$ 0